The END Fund
The END Fund is the only private philanthropic initiative solely dedicated to ending the most common neglected tropical diseases (NTDs).
Who We Are
Neglected tropical diseases (NTDs) are a group of parasitic and bacterial infectious diseases that affect more than 1.5 billion of the world’s most impoverished people, including 836 million children. Over 40% of the global NTD burden is concentrated in sub-Saharan Africa, where the END Fund focuses the majority of our work.
The END Fund focuses on delivering neglected tropical disease (NTD) treatments to those in need by growing and engaging a community of activist-philanthropists, managing high-impact strategic investments, and working in collaboration with government, NGO, pharmaceutical, and academic partners. We aim to take a systems approach to understanding, engaging with, and influencing the broad ecosystem of stakeholders working on ending NTDs.
Studies show that NTD treatment is the single most cost effective means of improving children’s attendance and increasing capacity to learn and concentrate in school. Just 50 cents funds a rapid-impact package of medication to treat an individual for the five most common NTDs, making it a best buy in public health.
As a fund, our unique model enables us to act quickly and effectively, with a proven ability to leverage efficiencies of the private sector and foster strong partnerships. We are able to mobilize resources from a diverse range of investors and direct them to partners who can deliver them where they will have the most impact. These strategic investments will help end the most prevalent NTDs by 2030.